CHRISTINE TURCOTTE: Open Payments
NPI 1275142796 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 54 payments from 10 companies in 2025. Trend: 2023 $809 · 2024 $807 · 2025 $879
Food & beverage: $768Education: $111
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $201 |
| Teva Pharmaceuticals USA, Inc. | 6 | $174 |
| Alkermes, Inc. | 5 | $151 |
| Axsome Therapeutics, Inc. | 13 | $138 |
| Neurocrine BioSciences, Inc. | 4 | $69 |
| HARMONY BIOSCIENCES LLC | 2 | $56 |
| Corium, LLC | 3 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Lundbeck LLC | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Qelbree, ARISTADA, Auvelity, INGREZZA, WAKIX, AUSTEDO XR, Azstarys, CAPLYTA.
Industry payments across WI — which companies pay providers there.
